QDQ

Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer

Product code
QDQ
Device name
Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer
Device class
Class 2
21 CFR
21 CFR 892.2090
Medical specialty
Radiology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
22
Summaries archived here
20 (direct download)
510(k) clearances (all years, FDA)
39 (all years; only the last 3 years are listed here)

FDA classification definition

A radiological computer assisted detection and diagnostic software for suspected lesions is an image processing device intended to aid in the detection, localization, and characterization of lesions suspicious for cancer on acquired medical images (e.g., mammography , MR, CT, ultrasound, radiography). The device detects, identifies and characterizes lesions suspicious for cancer based on features or information extracted from the images, and may provide information about the presence, location, and characteristics of the lesion to the user. Primary diagnostic and patient management decisions are made by the clinical user.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (22)

Last three years. Most recent: 2026-08-14.

NumberDecision dateApplicantDevice nameSummary
K2608982026-08-14Screenpoint Medical B.V.Transpara (2.1.0)PDF
K2600862026-08-12BeamWorks, Inc.CadAI-B DxPDF
K2603032026-07-28See-Mode Technologies Pty, Ltd.See-Mode Augmented Reporting Tool, Breast (SMART-B)PDF
K2607142026-06-26TherapixelMammoScreen® (5)FDA
K2538252026-06-15DeepHealth, Inc.Saige-DxPDF
K2536822026-04-29Quantib B.V.DeepHealth ProstateAIPDF
K2603202026-04-23Lunit, Inc.Lunit INSIGHT MMG (v1.1.10)PDF
K2537962026-03-26Lunit, Inc.Lunit INSIGHT DBT (V1.2)PDF
K2514742026-02-06Median TechnologiesMedian LCS (internal name) / eyonis LCS (trade name)…PDF
K2518732025-08-11DeepHealth, Inc.Saige-DxPDF
K2433412025-07-31Hologic, Inc.Genius AI Detection 2.0PDF
K2436792025-07-03TherapixelMammoScreen® (4)PDF
K2426832025-03-18Quibim S.L.QP-Prostate® CADPDF
K2417702025-03-05Siemens Healthcare GmbHProstate MR AI (VA10A)FDA
K2436882024-12-19DeepHealth, Inc.Saige-Dx (3.1.0)PDF
K2418312024-11-25Screenpoint Medical B.V.Transpara (2.1.0)PDF
K2417472024-11-18DeepHealth, Inc.Saige-DxPDF
K2404172024-11-08Icad, Inc.ProFound Detection (V4.0)PDF
K2426522024-10-04Lunit, Inc.Lunit INSIGHT DBT v1.1PDF
K2406972024-09-09See-Mode Technologies Pte, Ltd.See-Mode Augmented Reporting Tool, Thyroid (SMART-T)PDF
K2403012024-08-01TherapixelMammoScreen® (3)PDF
K2314702023-11-06Lunit, Inc.Lunit INSIGHT DBTPDF

20 summaries are archived here for direct download.

Official FDA classification page: QDQ
Classification and pathway per current FDA publications. Data from openFDA (CC0).